Thank you for your donation! Your payment is being processed. Please do not refresh or navigate away from this page.

diaTribe Musings 2022 No. 1 - CGM/Insulin Delivery


Join us for the 7th Annual diaTribe Musings Panel Discussions

Next Event: Tuesday, May 17, 2022

Tools to Reach Your Target: 

CGM and Smart Insulin Delivery

5:30-6:45pm EDT / 2:30-3:45pm PDT 

Every day is different with diabetes. Recent advances in technology are providing better tools for addressing the ups and downs of diabetes management. Continuous glucose monitoring (CGM) and new ways of delivering insulin can improve your daily life and long-term health by increasing your Time in Range – the percentage of each day you are meeting your glucose targets. Come to this panel to hear how you can leverage the latest developments to thrive each and every day.

Panel discussion with Q&A from 5:30-6:45pm EDT / 2:30-3:45pm PDT, with Community Networking and Expo Booths open beginning 15 minutes prior. Community Networking and Expo Booths will also remain open following the panel.


Our highly-regarded speakers are Dr. Ananta Addala, Stanford University; Laura Brandner, Abbott Diabetes Care; Dr. Jim Malone, Bigfoot Biomedical; Dr. David Price, Dexcom. The panel will be moderated by Diane Scherer of The diaTribe Foundation.



Ananta Addala DO MPH, Instructor, Division of Pediatric Endocrinology & Diabetes, Lucile Packard Children’s Hospital, Stanford University

Dr. Ananta Addala is a pediatric endocrinologist and physician scientist addressing disparities in pediatric type 1 diabetes management and outcomes. Dr. Addala has a longstanding research and clinical interest to promote equitable care for youth with type 1 diabetes informed by biological, social, psychological, and systemic determinants of health. In addition to her training in pediatric endocrinology, Dr. Addala holds an MPH with a focus on behavioral drivers of health and epidemiology. As a physician with a background in pediatric endocrinology, epidemiology, and behavioral health, she aims to build an evidenced based approach to addressing T1D disparities by systematically evaluating youth-, family-, provider-, and system-level barriers to optimal diabetes care in youth from low socioeconomic and racial/ethnic minority groups. To date, her publications have demonstrated that the disparities in pediatric T1D by socioeconomic status are worsening in the US, provider bias against public insurance is common, and public insurance mediated interruptions to diabetes technology adversely impact glycemic outcomes.She has also been leading the efforts to improve justice, equity, diversity, and inclusion in research at Stanford University through her leadership at Stanford Pediatrics Advancing Anti-Racism Coalition (SPAARC).


Laura Brandner, Director of Real World Evidence Programs at Abbott Diabetes Care

Laura is the director of Real World Evidence Programs at Abbott Diabetes Care. Her 15-year tenure at Abbott has included over 10 years in the diabetes division and a variety of impactful roles. She started at Abbott on the Professional Development Program – gaining experience in pharmaceutical manufacturing, diagnostics equipment, and vascular devices. In the diabetes division, she has held roles in R&D program management, commercial planning and forecasting, and spent five years working in innovation and digital platforms where she started as a product manager for the FreeStyle LibreLink app and LibreView data management system, eventually leading a team of product managers as the digital ecosystem grew. In 2019, she moved into a newly-created role to lead real world evidence (RWE) programs for the diabetes division. The RWE team is responsible for clinical evidence generation from real world data sources, both internal and external. Laura has a BS in Chemical Engineering from Purdue University and a Master of Business Administration (MBA) from UC Berkeley-Haas.

Jim Malone MD, Chief Medical Officer at Bigfoot Biomedical

Jim Malone MD is a diabetes specialist and currently Chief Medical Officer at Bigfoot Biomedical since January 2020. Previously, he retired from Eli Lilly & Company in 2018, where he worked for 21 years in global diabetes research focused on the development of new diabetes products including insulin analogs and GLP-1 Receptor Agonists, and insulin delivery devices. Prior to joining Lilly, Jim was in private practice for 12 years as a diabetes specialist in Indianapolis. He is a graduate of Butler University and the Indiana University School of Medicine. His specialty training included a residency in Internal Medicine at Methodist Hospital in Indianapolis (now part of the IU Health system) and a clinical fellowship in Diabetes and Metabolism at the Joslin Diabetes Center in Boston. Jim was an Associate Clinical Professor (adjunct), and taught Endocrinology at Marian University College of Osteopathic Medicine in Indianapolis from 2019-2020. Jim joined the Indiana JDRF Board of Directors in 2012 and remains a board member and volunteer. Currently he is immediate past-president of the Indiana Community Board of Directors. Jim is an avid cyclist and rides with the Indiana JDRF Bike Team and has gone on several European bike rides with professional colleagues. He currently resides in Indianapolis with his wife Jeanne and enjoys spending time with his three granddaughters and new grandson.


David Price MD, Vice President of Medical Affairs at Dexcom

David Price MD is Vice President of Medical Affairs at Dexcom. His responsibilities have included leading the strategy, design, and interpretation of clinical trials and usability studies, developing and executing publication strategies, supporting investigator-initiated studies, and providing medical input into product development and risk management processes. Dr. Price leads clinical discussions with regulators, advocacy groups, professional societies, payers and strategic accounts. He successfully led the Dexcom team in a FDA advisory panel meeting to expand the indication for Dexcom CGM to replace BG measurements for diabetes management. He ideated and led the steering committees for the DIAMOND and MOBILE Studies that established the value of CGM in diverse insulin users. Dr. Price previously worked at LifeScan and was responsible for developing clinical decision support solutions and leading the clinical research program.  Dr. Price received his undergraduate baccalaureate degree from Washington University in St. Louis and his medical degree from the Ohio State University. He completed his internship and internal medicine residency at the Maine Medical Center and a clinical fellowship at the Joslin Diabetes Center and Harvard Medical School. Dr Price serves on the Board of Directors of the Behavioral Diabetes Institute.



Diane Scherer, Development Director at The diaTribe Foundation

Diane is passionate about connecting corporations and individual philanthropists with meaningful causes that make our world inspiring, healthy, and equitable. She brings her combined 15+ years of non-profit fundraising experience and 37 years as a person with Type 1 Diabetes to The diaTribe Foundation.  She earned her BSBA from the Warrington School of Business at University of Florida. After two years working in banking, a "career epiphany" led her to pivot to the non-profit sector and she completed a Masters in Social Work at Wurzweiler School of Social Work. She has subsequently had roles that included a $5-million grant portfolio on the issues of mental health and special needs in the New York Jewish community, and annual, capital, and planned giving fundraising roles where she has solicited millions of dollars for social causes. Diane is a runner, having completed 2 half-marathons and fundraising for diabetes organizations to keep her motivated, and she enjoys her Peloton bike. She has never known a life without Type 1 diabetes and is on a quest to get a perfect CGM line after her favorite food - sushi (very hard to carb count!). She lives in Florida with her husband and three children.


About diaTribe Musings

Previously known as Musings Under the Moon, when it was a single live event at the ADA Scientific Sessions, diaTribe Musings is now one of The diaTribe Foundation's most treasured ongoing virtual programs, engaging a diverse audience in thought-provoking dialogue and providing an opportunity to connect healthcare providers, business leaders, people living with diabetes, advocates, families, entrepreneurs, and policymakers. Musings tickets are complimentary thanks to the generous support of our sponsors. We welcome anyone interested in learning about the massive shifts and opportunities occurring in the world of diabetes. Please spread the word and share this event with anyone interested in learning more about diabetes. Join the conversation on Twitter with #diaTribeMusings.


Past Musings Events

December 14, 2021

October 19, 2021

September 2, 2021

July 14, 2021

May 13, 2021

September 1, 2020

Coverage of all past Musings events in diaTribe Learn


Thank you to our sponsors for making this event possible


Gold Sponsors



Silver Sponsors






How You Can Join Us

Sign Up For diaTribe Updates!

We will never sell your data and we promise to keep your details safe and secure. For more information see our privacy policy.